REFERENCES
  1. Ezhilarasan D. Dapsone-induced hepatic complications: it’s time to think beyond methemoglobinemia. Drug Chem Toxicol . 2021;44(3):330-333. doi:10.1080/01480545.2019.1679829
  2. Agrawal S, Agarwalla A. Dapsone hypersensitivity syndrome: a clinico-epidemiological review. J Dermatol . 2005;32(11):883-889. doi:10.1111/j.1346-8138.2005.tb00865.x
  3. Garcia A, Yi NJ, Lee KB, et al. Fulminant hepatitis linked to dapsone hypersensitivity syndrome requiring urgent living donor liver transplantation: a case report [published correction appears in Pediatr Transplant. 2018 Aug;22(5):e13224. doi: 10.1111/petr.13224].Pediatr Transplant . 2014;18(7):E240-E245. doi:10.1111/petr.12343
  4. Lorenz M, Wozel G, Schmitt J. Hypersensitivity reactions to dapsone: a systematic review. Acta Derm Venereol . 2012;92(2):194-199. doi:10.2340/00015555-1268
  5. Devarbhavi H, Raj S, Joseph T, Singh R, Patil M. Features and Treatment of Dapsone-Induced Hepatitis, Based on Analysis of 44 Cases and Literature Review. Clin Gastroenterol Hepatol . 2017;15(11):1805-1807. doi:10.1016/j.cgh.2017.05.031
  6. Prakash S, Gosse M, Tanaka T. Dapsone-Induced Granulomatous Cholestatic Hepatitis Unmasked by Steroid Taper: A Case Report.Case Rep Gastroenterol . 2023;17(1):362-366. Published 2023 Dec 11. doi:10.1159/000534818
  7. Lee KB, Nashed TB. Dapsone-induced sulfone syndrome. Ann Pharmacother . 2003;37(7-8):1044-1046. doi:10.1345/aph.1C432